Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Methyldopa Prices, Demand and Supply Overview
Methyldopa prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 51.5/KG in Q1 to USD 54.6/KG by Q2 as spring hypertension management and pregnancy-associated hypertension treatment procurement and firmer aromatic amino acid synthesis feedstock costs drove consistent buying following the brief Q1 2026 pricing correction. Globally, the average rose from USD 36.70/KG in Q1 to USD 38.90/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 39.20-43.80/KG is expected, with continued firming on Middle East supply disruptions and growing pregnancy-associated hypertension and antihypertensive sector demand globally.
Methyldopa is a centrally acting antihypertensive produced by multi-step asymmetric synthesis from 3,4-dimethoxybenzaldehyde or vanillin precursors, proceeding through aldol condensation, asymmetric reduction or optical resolution steps to introduce the alpha-methyl group and amino acid functionality, then selective demethylation to yield the L-alpha-methyl-3,4-dihydroxyphenylalanine active pharmaceutical ingredient. The compound undergoes intraneuronal decarboxylation and beta-hydroxylation to alpha-methylnorepinephrine, which stimulates presynaptic alpha-2 adrenoceptors in the brainstem nucleus tractus solitarius to reduce central sympathetic outflow, lowering peripheral vascular resistance and blood pressure without significant reflex tachycardia. The largest pull comes from pregnancy-associated hypertension management, where methyldopa retains the most extensively documented fetal safety profile and is recommended by international obstetric guidelines as first- or second-line therapy for gestational and pre-eclamptic hypertension across gestation trimesters. Antihypertensive use where beta-blockers are contraindicated, including reactive airway disease and certain vascular conditions, and secondary hypertension management add further demand. Maternal health programme procurement by low- and middle-income country health systems adds further growing demand. Aromatic amino acid synthesis feedstock costs and regional API capacity all feed into the price.
Methyldopa Price Forecast for 2026
The balance of supply and demand for methyldopa through H2 2026 leans moderately firm. Aromatic amino acid synthesis feedstock costs firmed from Middle East supply disruptions. Pregnancy-associated hypertension treatment demand is growing with expanding antenatal care coverage and obstetric hypertension guideline adoption in low- and middle-income health systems.
The main upside risk is synthesis feedstock cost increases alongside accelerating maternal health programme procurement. The main downside risk is continued Chinese API surplus and competitive generic pricing maintaining price pressure below forecast.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 39.20 - 43.80 | Synthesis cost firming and antihypertensive/obstetric demand |
| United States | 41.60 - 46.20 | Steady pregnancy hypertension and antihypertensive demand holds firm |
| China | 27.70 - 32.30 | Domestic API capacity keeps it the most affordable |
| Germany | 54.90 - 59.50 | High synthesis and energy costs keep it the most expensive |
| India | 39.60 - 44.20 | Growing maternal health and export Rx demand holds a firm middle |
For the Quarter Ending June 2026
Methyldopa Prices Q2 2026:
- United States: USD 44.4/KG
- China: USD 30.9/KG
- Germany: USD 54.6/KG
- India: USD 41.8/KG
Methyldopa Prices in the United States
US Methyldopa prices averaged USD 44.4/KG in Q2 2026, up 6.0% from USD 41.9/KG in Q1 2026. Firmer synthesis feedstock costs and spring pregnancy hypertension and antihypertensive formulation procurement drove consistent buying following the Q1 correction.
Why did the price of Methyldopa change in Q2 2026 in the United States?
Firmer aromatic amino acid synthesis feedstock costs raised the API production floor. Pregnancy-associated hypertension and general antihypertensive formulation procurement lifted buying. Maternal health programme and obstetric clinic procurement provided additional buying support near USD 44.4/KG.
Methyldopa Prices in China
Chinese Methyldopa prices averaged USD 30.9/KG in Q2 2026, up 5.8% from USD 29.2/KG in Q1 2026, the lowest among the tracked markets. Spring antihypertensive export and domestic obstetric procurement lifted buying. Firmer domestic synthesis costs raised the production floor despite domestic API capacity.
Why did the price of Methyldopa change in Q2 2026 in China?
Spring antihypertensive and obstetric formulation export and domestic procurement lifted buying. Firmer domestic aromatic synthesis feedstock costs raised the production floor. Domestic API capacity kept China the most affordable source.
Methyldopa Prices in Germany
German Methyldopa prices averaged USD 54.6/KG in Q2 2026, up 6.0% from USD 51.5/KG in Q1 2026, the highest among the tracked markets. Higher synthesis feedstock and energy costs elevated European API production economics. Consistent pregnancy hypertension, general antihypertensive, and maternal health programme demand maintained consistent buying.
Why did the price of Methyldopa change in Q2 2026 in Germany?
Higher aromatic amino acid synthesis feedstock and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to aromatic synthesis supply chains. Consistent obstetric and general antihypertensive procurement maintained buying near USD 54.6/KG.
Methyldopa Prices in India
Indian Methyldopa prices averaged USD 41.8/KG in Q2 2026, up 6.1% from USD 39.4/KG in Q1 2026. Growing maternal health, export, and domestic antihypertensive demand supported buying. Firmer synthesis import costs raised the production floor through the quarter.
Why did the price of Methyldopa change in Q2 2026 in India?
Growing pregnancy hypertension and general antihypertensive export and domestic procurement lifted buying. Firmer aromatic synthesis import costs raised the production floor. Maternal health programme export demand provided additional buying support near USD 41.8/KG.
For the Quarter Ending March 2026
Methyldopa Prices Q1 2026:
- United States: USD 41.9/KG
- China: USD 29.2/KG
- Germany: USD 51.5/KG
- India: USD 39.4/KG
Methyldopa Prices in the United States
US Methyldopa prices averaged USD 41.9/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-year-end antihypertensive and obstetric procurement moderation and soft synthesis costs eased the market before the Q2 spring recovery.
Why did the price of Methyldopa change in Q1 2026 in the United States?
Post-year-end antihypertensive and pregnancy hypertension procurement moderation reduced buying urgency. Soft synthesis feedstock costs eased the production floor. The market eased to USD 41.9/KG before the Q2 spring obstetric and antihypertensive procurement recovery.
Methyldopa Prices in China
Chinese prices averaged USD 29.2/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-Lunar New Year procurement moderation and soft synthesis costs held the market near USD 29.2/KG.
Why did the price of Methyldopa change in Q1 2026 in China?
Post-Lunar New Year antihypertensive export and domestic procurement moderation reduced buying urgency. Soft domestic synthesis costs eased the production floor. The market eased to USD 29.2/KG before the Q2 recovery.
Methyldopa Prices in Germany
German prices averaged USD 51.5/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-year-end obstetric and antihypertensive procurement moderation and soft synthesis costs eased the European market near USD 51.5/KG.
Why did the price of Methyldopa change in Q1 2026 in Germany?
Post-year-end obstetric and general antihypertensive procurement moderation reduced buying urgency. Soft synthesis feedstock and energy costs eased the production floor. The market eased to USD 51.5/KG before the Q2 spring procurement recovery.
Methyldopa Prices in India
Indian prices averaged USD 39.4/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-holiday procurement moderation and soft synthesis costs held the market near USD 39.4/KG.
Why did the price of Methyldopa change in Q1 2026 in India?
Post-holiday antihypertensive and maternal health procurement moderation reduced buying urgency. Soft synthesis import costs eased the floor. The market eased to USD 39.4/KG before the Q2 spring recovery.
Quarterly Methyldopa Price Trends
Global Methyldopa prices firmed through Q3 and Q4 2025 on antihypertensive and obstetric season procurement, corrected in Q1 2026 on post-holiday moderation, then surged in Q2 2026 on recovering spring demand. The average rose from USD 36.0/KG in Q2 2025 to USD 36.72/KG in Q3 and USD 37.45/KG in Q4, eased to USD 36.70/KG in Q1 2026, then surged to USD 38.90/KG in Q2 2026, a net gain of about 8.0% over the window. Aromatic amino acid synthesis cost cycles and pregnancy hypertension and antihypertensive procurement seasonality drove the overall pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 38.90 | +6.0% | ↑ Rising |
| Q1 2026 | 36.70 | -2.0% | ↓ Falling |
| Q4 2025 | 37.45 | +2.0% | ↑ Rising |
| Q3 2025 | 36.72 | +2.0% | ↑ Rising |
| Q2 2025 | 36.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
What was Methyldopa Price in 2025?
Methyldopa prices firmed steadily through 2025 on consistent pregnancy hypertension and antihypertensive demand. The global average opened near USD 35.5/KG in Q1 2025 and closed at USD 37.45/KG in Q4, a full-year gain of about 5.5%. Growing maternal health programme procurement and synthesis feedstock cost dynamics drove the upward trajectory throughout the year.
Methyldopa Prices in the United States in 2025
US prices firmed from about USD 41.5/KG in Q1 2025 to USD 42.8/KG by Q4, a gain of 3.1%. Consistent pregnancy hypertension and general antihypertensive demand supported the upward trend.
Methyldopa Prices in China in 2025
Chinese prices firmed from roughly USD 28.8/KG in Q1 2025 to USD 29.8/KG by Q4, a gain of 3.5%. Growing antihypertensive and maternal health export demand drove the firming through the year.
Methyldopa Prices in Germany in 2025
German prices firmed from about USD 51.0/KG in Q1 2025 to USD 52.5/KG by Q4, a gain of 2.9%. Consistent obstetric, antihypertensive, and maternal health programme demand and firm synthesis costs supported.
Methyldopa Prices in India in 2025
Indian prices firmed from roughly USD 39.0/KG in Q1 2025 to USD 40.2/KG by Q4, a gain of 3.1%. Growing maternal health export and domestic antihypertensive demand drove consistent firming through the year.
How We Can Help
Expert Market Research: Your Source for Real-Time Methyldopa Price Intelligence
Expert Market Research tracks Methyldopa prices continuously across every major producing and consuming region. The team traces causation through aromatic amino acid synthesis feedstock economics, pregnancy hypertension and antihypertensive prescription cycles, and regional API production capacity. Contact Expert Market Research today for Methyldopa pricing data, bespoke market analysis, and strategic procurement advisory.
Pricing Plans
Upto 15% Off
USD
-
$799 $699
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Key Questions Answered in the Report
Hypertension management in pregnancy, including gestational and pre-eclamptic hypertension, as first-line or second-line therapy per international obstetric guidelines takes the largest share, given its extensive established fetal safety record. General antihypertensive use in patients where beta-blockers are contraindicated and secondary hypertension management also consume significant volumes globally.
The Q2 2026 average was USD 44.4/KG in the United States, USD 30.9/KG in China, USD 54.6/KG in Germany, and USD 41.8/KG in India. Germany remains the highest-priced market.
The global average rose from USD 36.70/KG in Q1 to about USD 38.90/KG in Q2, a gain of around 6.0%. Spring obstetric and antihypertensive procurement and firmer synthesis feedstock costs drove the H1 recovery from the Q1 correction.
Post-year-end obstetric and antihypertensive procurement moderation reduced buying urgency. Soft aromatic amino acid synthesis feedstock costs eased the API production floor before the Q2 spring maternal health and antihypertensive procurement recovery.
The global average is expected in the USD 39.20 to 43.80/KG range for H2 2026, with continued firming as synthesis feedstock costs stay elevated and pregnancy hypertension and antihypertensive sector demand grows globally.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on obstetric and antihypertensive demand, and China prices lowest on domestic API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to aromatic amino acid synthesis feedstock costs, pregnancy hypertension management guideline adoption, and maternal health programme procurement cycles. Obstetric care access expansion data and synthesis precursor pricing are key signals.
China and India hold the largest methyldopa API synthesis capacity. Any aromatic synthesis feedstock cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time obstetric and antihypertensive formulation contracts around synthesis cost and seasonal cycles, build cover when aromatic feedstock signals tighten, and monitor maternal health programme expansion as the primary demand signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
- Report in Excel Format
- 3 Months Price Forecast
- Historical Prices for the Past 3 Years
-
Summary Of Factors Influencing Prices
- Current Price Overview
- 3-Month Price Forecast
- Historical Price Summary
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.